Related Experiment Videos
[Decreased adenosine deaminase activity in the T-lymphocytes in Hodgkin's disease]
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete
|January 1, 1983
Insights
Adenosine deaminase activity in T-lymphocytes is reduced in patients with Hodgkin's disease. This decrease was specific to T-lymphocytes and not observed in plasma or erythrocytes.
Area of Science:
- Immunology
- Biochemistry
Background:
- Hodgkin's disease is a cancer of the lymphatic system.
- T-lymphocytes play a crucial role in immune responses.
Purpose of the Study:
- To investigate adenosine deaminase activity in T-lymphocytes of Hodgkin's disease patients.
- To compare enzyme activity between patients and healthy individuals.
Main Methods:
- Collected blood samples from Hodgkin's disease patients and healthy controls.
- Isolated T-lymphocytes from blood samples.
- Measured adenosine deaminase activity in T-lymphocytes, plasma, and erythrocytes.
Main Results:
- Adenosine deaminase activity was significantly decreased in T-lymphocytes of Hodgkin's disease patients compared to controls.
- No significant difference in adenosine deaminase activity was found in plasma or erythrocytes between the groups.
Conclusions:
- Reduced adenosine deaminase activity in T-lymphocytes may be a biomarker for Hodgkin's disease.
- The findings suggest a specific impairment of T-lymphocyte function in this condition.
Abstract:
The adenosine desaminase activity of T-lymphocytes of patients with Hodgkin's disease has been investigated. As compared with the adenosine desaminase activity of T-lymphocytes of healthy control persons, the activity in Hodgkin's disease is decreased, but not in plasma or erythrocytes.